On the other hand, IL-15 enhanced NK cytotoxicity, down-regulated NKP46 expression (which was higher in SLE patients), and enhanced NKG2D and NKAT-2 (which were lower in SLE patients) on NK cells from SLE patients. The gene discussed is KIR2DL3; the disease is systemic lupus erythematosus.